A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer  by He, Ni et al.
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Objective:  Malignant  axillary  lymph  nodes  are  an important  predictor  for  breast  cancer  recurrence,  but
invasive  dissection  or biopsy  is required  for the  diagnosis.  We  determined  whether  and  how  malignant
nodes  could  be  diagnosed  preoperatively  with  magnetic  resonance  (MR)  imaging.
Materials  and  methods:  We  obtained  MR  images  of  all women  evaluated  for  breast  cancer  at  the  Sun  Yat-
Sen University  Cancer  Center  in 2010  and  correlated  the  image  characteristics  of  each  axillary  node  with
the pathologic  diagnosis  of the  same  node.
Results: We  analyzed  251  nodes  (117  benign;  134  malignant)  from  136  women  (mean  age, 44  years;
range,  20–67).  Mean  diameter  of  the  nodes  was  18  mm  (range,  5–58  mm).  With  pathologic  diagnosis  as
the reference  standard,  MRI-based  interpretations  were  66.4%  sensitive,  94%  speciﬁc,  and  79%  accurate.
Diameter,  pathologic  type,  apparent  diffusion  coefﬁcient  value  (ADC,  b  = 500  and  800),  time-intensity
curve  (TIC)  type  of  breast  tumors  correlated  with  node  metastasis;  ADC  value  (b  = 500 and  800),  TIC
type,  early  enhancement  rate,  long-axis,  short-axis,  shape,  margin  and  the  location  of nodes  correlated
with  node  metastasis  (P  < 0.001  for  all).  Tumor  immunohistochemistry  results  for  estrogen  receptors,
progesterone  receptors,  c-erbB-2,  vascular  endothelial  growth  factor,  and  Ki67  were  not.  An  MRI-based
lymph  node  scoring  system  based  on  these  correlations  had  a speciﬁcity  of  91%,  a  sensitivity  of  93%,  and
an area  under  the  ROC  curve  of 0.95  (P  <  0.001).
Conclusion:  Metastatic  axillary  lymph  nodes  can  be  accurately  diagnosed  by  MR  in  women  with  early
breast  cancer  preoperatively  and  non-invasively.  The  scoring  system  appears  to be superior  to current
methods.
© 2012 Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.. Introduction
World wide, breast carcinoma is the most common form of can-
er in women [1,2]. In turn, malignant axillary lymph nodes are
n important predictor of breast cancer recurrence [3].  Pathologic
nalysis of these nodes currently requires axillary lymph node dis-
ection or sentinel lymph node biopsy, both of which are invasive
rocedures. An accurate, preoperative, non-invasive staging proce-
ure for these nodes would eliminate the need for these invasive
rocedures.
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E-mail addresses: 61684754@qq.com (N. He), xiechm@sysucc.org.cn (C. Xie),
eiwd@sysucc.org.cn (W.  Wei), 1253719670@qq.com (C. Pan), 7344362@qq.com
W.  Wang), 409109980@qq.com (N. Lv), mit@caca.sina.net (P. Wu).
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Open access under CC BY-NC-ND license.Breast magnetic resonance imaging (MRI) has improved
tremendously over the past two  decades. The use of contrast
agents, in particular, gadolinium diethylenetriamine penta-acetic
acid (Gd-DTPA); improvements in MR  technology, including mag-
netic ﬁeld homogeneity and optimized gradients; and the use
of surface coils and high-resolution, 3D-gradient echo sequences,
have all contributed to this improvement [4].  Diffusion-weighted
MRI  (DWI-MRI) and dynamic contrast-enhanced magnetic reso-
nance imaging (DEC-MRI) are currently widely used to distinguish
benign from malignant breast tumors on the basis of tumor biol-
ogy and functional characteristics. However, these methods have
seldom been used in evaluating axillary lymph nodes. Current diag-
nostic criteria of malignant axillary lymph nodes are based only on
morphology, produce mixed results, and so remain controversial
[4–7]. We  sought to determine whether and how malignant nodes
could be diagnosed preoperatively and noninvasively with MRI  by
using both morphologic and functional criteria.
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Fig. 1. Different types of DCE-MRI TIC [8].  Type I (persistent): within 6 min  after contrast-agent is injected, tumor intensity continues to increase but does not reach peak-
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lignal  intensity; type II (plateau): peak-time is within 2 or 3 min  after the contrast
washout): peak-time is within 2 or 3 min  after the contrast agent is injected, then 
. Materials and methods
.1. Study population
The study was approved by the Institutional Review Board and
thical Review Committee of the Sun Yat-Sen University Can-
er Center, and written informed consent was obtained from all
omen.
Between December 2009 and October 2010, we approached all
omen undergoing breast MRI  examinations at the Sun Yat-Sen
niversity Cancer Center. Indications for breast MRI were inconclu-
ive mammographic or ultrasound evaluation and deﬁned clinical
tage of breast cancer pre-operation, especially in women with
chedule undergoing breast-conserving surgery. Pregnant women,
omen with a contraindication for MRI  or of MRI  contrast material,
r a history of chemotherapy or radiation therapy within 12 months
efore MRI  were excluded.
After MRI  evaluation, women determined by MRI  to be benign
reast neoplasms underwent biopsy or surgical resection under-
ent biopsy or surgical resection, and lymph node of highest
core evaluated with our scoring system in benign breast neoplasm
atient underwent ultrasound-guided biopsy. Women  with malig-
ant tumors underwent mastectomy or breast-conserving surgery,
ased on the guiding of NCCN 2010. In all cases, all breast tumors
nd axillary lymph nodes were sampled for later analysis by two
xperienced pathologists.
.2. Technical speciﬁcations of MR  imaging
Breast and axillary lymph node images were obtained with a 1.5-
 scanner (GE signa HDx, General Electric, Milwaukee, WI,  USA).
ime-intensity curve (TIC), maximum slope of increase pseudo-
olor map  (MSI map), signal-enhancement ratio pseudo-color map
SER map), apparent diffusion coefﬁcient pseudo-color map  (ADC
ap), and exponential apparent diffusion coefﬁcient pseudo-color
ap  (EADC map) were created with a SUN ADW 4.3 workstation
General Electric, Milwaukee, WI,  USA). All patients were scanned
n the standard prone position with a dedicated 8-channel phased-
rray breast coil.
We  identiﬁed several morphologic characteristics—tumor
iameter, node short-axis length, node long-axis length, node
hape (short-long axis ratio), node margin, and node anatomical
ocation—and functional MRI  characteristics—ADC values (b = 500t is injected, then the intensity of the signal rises or falls by less than 10%; type III
tensity of the signal fades quickly by more than 10%.
and 800), TICs, early-stage enhancement rate of the node, and a high
signal of the node on the DWI  map—as being potentially diagnostic
of metastases. Every morphologic characteristic of breast tumors
or lymph nodes visible on MRI  was scored as zero, one, or two as
premier training by two radiologists, with 5 and 6 years of experi-
ence in reading breast MRIs, without knowing any of the patients’
clinical data. Scores were summed for every breast tumor and node,
ﬁnal MRI  diagnose was quantitative. The two scores were averaged
for each characteristic. The degree of agreement between these two
judges was  also assessed with the kappa statistic.
2.3. Imaging protocols
1. Diffusion-weighted images (DWI) were ﬁrst acquired using a
single-shot spin echo-echo planer imaging (SE-EPI) sequence in
the axial plane (repetition time/echo time, 5000/155 ms;  ﬁeld
of view, 34 cm ×34 cm;  slice thickness, 4 mm;  spacing, 0 mm;
matrix, 128 × 128; NEX 4.00). Sensitizing diffusion gradients
were applied sequentially on the x, y, and z axes with b values of
0 and 500, 800 s/mm2.
2. Conventional breast MRI  was  then performed:
i. Axial T1-weighted, fast-spin echo (FSE) sequence (repeti-
tion time/echo time, 467/9.9 ms;  slice thickness, 5 mm/1  mm;
matrix 320 × 224, NEX 1.00).
ii. Axial T2-weighted, short-time inversion recovery (STIR)
sequence (repetition time/echo time, 6000/140 ms;  slice
thickness, 5 mm/1  mm;  matrix 320 × 190, NEX 2.00).
iii. Sagittal T1-weighted, fast-spin echo (FSE) sequence
(repetition time/echo time: 617/15.7 ms;  slice thickness,
5 mm/1  mm;  matrix 320 × 224; NEX: 1.00).
iv. Sagittal fat-saturated, T2-weighted and FSE sequence
(repetition time/echo time, 2500/82.9 ms;  slice thickness,
5 mm/1  mm;  matrix 320 × 224, NEX 1.00).
v. Conventional MR imaging was followed by 3-dimensional,
dynamic contrast-enhanced MRI  with Gd-DTPA.
3. Sagittal, fat-suppressed T1-weighted sequences (3D-gradient
echo imaging) were obtained using a dynamic, gadolinium-
enhanced MR  imaging protocol (TR/TE, 5.8/2.8 ms;  FOV
35 cm ×35 cm;  MTX  320 × 320; slice thickness, 2 mm;  NEX
1) with Gd-DTPA (Magnevist; Schering, Berlin, Germany;
0.1 mmol/kg body weight; injection rate, 3 mL/s) administered
with an MRI-compatible power injector (Mississippi XD2000,
Ulrich, UlM, Germany). T1-weighted sequences were obtained
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Fig. 2. Left axillary metastatic node of a 35-year-old woman with a 45-mm tumor of invasive ductal carcinoma (IDC) identiﬁed on DCE-MRI and veriﬁed with pathologic
analysis.  (A) Two high-signal tumors on sagittal DCE-MRI map  (red arrows). (B) Typical type III TICs (washout) of the two breast tumors (Lines 2–3). (C and D) The pathologic
diagnosis of the second and third tumors was invasive ductal carcinoma (Hematoxylin & Eosin, 200×). (E) A nodular foci of high signal intensity on an axial T1-weighted,
fast-spin echo sequence imaging (White arrow). (F) The same oval high-signal intensity node on a sagittal, fat-saturated T1-weighted and fast-spin echo sequence (White
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without Gd-DTPA as basic standard images, identical T1-
weighted sequences were obtained with this same protocol
every 56 s at the same time of bolus injection with Gd-DTPA,
total 8 times in 8 min. A series of 9 times sequences were
used to cumulate the early-enhancement rate and contrast-
enhancement curve with a SUN ADW 4.3 workstation.
. The MRI  scans of every patient were reconstructed using three-
dimensional maximum intensity projection (3-D MIP), and the
locations of suspected axillary lymph nodes were described in
relationship to three anatomical levels (level I, the area outside
the pectoralis minor; level II, the area under pectoralis minor;
and level III, area at the top of pectoralis minor) and to important
tissues (e.g., nerves, vessels, muscles, and bones).
.4. Region of interest area
. Dynamic contrast uptake analysis was performed by placing a
region of interest (ROI) on the most enhanced area of the breast
tumors and axillary lymph nodes and created time-intensity
curves (TICs). ROI located on a maximum diameter scan and
its area was 20 mm2 on DEC map. All TICs were classiﬁed into
Murakami’s three types [8]:  persistent, plateau, and washout
(Figs. 1 and 2).
. All ADC values were calculated according to the formula:
DC = −
(
1
b
)
ln(S/So),
here So and S were the signal intensities in the ROI obtained with
ifferent gradient factors (b = 500, b = 800). To obtain an accurate
DC value of the suspected breast tumors and axillary lymph nodes,
he ROI was placed within the most enhanced portion on the EADC
ap, avoiding regions of necrotic, cystic, and hemorrhagic change.) Microscopic appearance of the node showing metastatic cancer (Hematoxylin &
ROI located on a maximum diameter scan and its area was  20 mm2
on ADC map  (Fig. 3).
2.5. Pathologic analysis
Numbers were assigned to the nodes sampled with dissection or
biopsy, and their corresponding images on the MR  images received
the same numbers to allow the two diagnoses for each node to be
compared (Fig. 4).
A physician with both surgical and radiological licenses was in
charge of labeling the lymph node samples. She took part in every
MRI  examination and in the surgery of every enrolled patient.
First, the sentinel lymph nodes were labeled. All women with
breast malignancies underwent SLN biopsy with the blue-dye
method (Fig. 4A). The SLNs were removed at the beginning of
the operation, their location established with coordinates from
clear anatomical landmarks, numbered to correspond with the
associated ﬁnding on the MR  images, and sent to frozen section
examination immediately.
Then, if the patient accepted axillary dissection to level II or to
level III, samples from nodes in these two levels were removed
during the operation and labeled. Nodes at the level I were the
last to be removed and normally departed from breast sample
after surgery. So, the whole axillary tissue sample including lymph
node and fatty tissue was  divided into three parts from level I to
level III.
After surgery, each node appearing on MR images (those larger
than 5 mm)  was removed from 3 samples of level I to level III, num-
bered to correspond with that on the MRI  image, and labeled with
the level of axillary dissection.
Finally, residual fatty tissue was submersed in acetone to detect
any small lymph nodes that might have been overlooked. If present,
they were removed and labeled. These nodes were too small to
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Fig. 3. Diffusion-weighted-MRI imaging of breast cancer and metastatic lymph nodes (b = 800). (A and B) Two invasive ductal carcinoma tumors of a 35-year-old woman (No.
1  and No. 2, black arrows) with bilateral breast cancer, identiﬁed on a DWI  original diagram (A) and the apparent diffusion coefﬁcient (ADC) pseudo diagram (B). Their ADC
values were 1.050 × 10−3 mm/s and 0.999 × 10−3 mm/s  (black arrows). (C) Pathologic result for the right breast tumor (No. 1, Hematoxylin & Eosin, 200×). (D) Pathological
result for the left breast tumor (No. 2, Hematoxylin & Eosin, 200×). (E and F) No. 6 and No. 7, two metastatic lymph nodes from the same patient, had similar characteristics;
ADC  values were 0.991 × 10−3 mm/s  and 0.911 × 10−3 mm/s  (red arrows). (G and H) Microscopic appearance of two metastatic lymph nodes (No. 6 and No. 7, Hematoxylin
&  Eosin, 400×).
Fig. 4. Three axillary lymph nodes from a 39-year-old breast cancer patient marked and numbered on the MRI map  and on the dissected specimens. (A) The sentinel lymph
node  (No. 1) dyed blue during surgery (arrow). (B) Suspicious lymph nodes marked on an MRI  map  pre-operatively (white arrows, Nos. 1–3). (C) Nodes were identiﬁed on
specimens obtained preoperatively through axillary lymph node dissection and numbered the same as their images on the MRI  map. (D) Cutaway view of the sentinel lymph
node  (No. 1). (E) Microscopic appearance of the sentinel lymph node (No. 1, Hematoxylin & Eosin, 40×).
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Table  1
Performance characteristics of a new, MRI-based preoperative node scoring system for detecting metastatic lymph nodes in women with breast cancer, by axillary level of
the  nodes.
Axillary levela MRI  diagnosis Pathologic
diagnosis
PPV, % NPV, % PLV, % NLV, % Se, % Sp, % Ac, % Youden’s Index Kappa
+ −
Ib + 90 19 82.6 1.9 34.6 13.8 86.5 97.5 96.2 0.84 0.82
− 14  735
IIc + 16 6 72.7 4.8 27.8 5.1 50.0 98.2 93.8 0.48 0.56
−  16 319
IIId + 2 1 66.7 16.7 6.9 0.7 33.3 95.2 18.5 0.29 0.35
− 4 20
PPV: positive predictive value; NPV: negative predictive value; PLV: positive likelihood radio; NLV: negative likelihood radio; Se: sensitivity; Sp: speciﬁcity; Ac: accuracy.
a Axillary anatomical level: level I, the area outside of laterals pectoralis minor; level II, the area under pectoralis minor; level III, the area at the top of pectoralis minor.
b 2 = 581.7, P < 0.001.
c 2 = 116.8, P < 0.001.
b
r
n
ﬁ
a
g
e
i
o
t
d
w
m
N
2
r
i
u
r
s
l
a
t
i
t
b
m
T
a
P
o
o
r
t
(
c
id Fisher’s exact test, P = 0.12.
e detected by MRI, so they contributed to the pathologic analysis
esults but provided no accurate MRI  information.
After standard pathologic examination [9],  breast tumors and
odes were sliced into 4-mm sections and embedded in paraf-
n, after which 3-m-thick slices were cut from each section
nd stained with hematoxylin & eosin. The expression of estro-
en receptors (ER), progesterone receptor (PR), c-erbB-2, vascular
ndothelial growth factor (VEGF), and Ki67 was determined by
mmunohistochemical methods.
All samples were evaluated for evidence of cancer by two pathol-
gists with 10 and 12 years of experience and who were blinded
o the MRI  results during the initial evaluation of the tissues. The
egree of agreement between these two judges was  also assessed
ith the kappa statistic.
Digital pictures of all sections were obtained at a 1.5-
agniﬁcation with a digital camera (Leica, Rijswijk, The
etherlands) mounted on top of a standard microscope (Leica).
.6. Statistical methods
Range, arithmetic means, and standard deviations (SD) are
eported for continuous data. Means were compared using
ndependent-sample t tests and homogeneity tests of variances
sing Levene’s test. Absolute and relative frequencies were
eported for categorical data, which were compared with the Chi-
quare test or Fisher exact test, as appropriate.
The positive predictive value, negative predictive value, positive
ikelihood radio, negative likelihood radio, sensitivity, speciﬁcity,
ccuracy, Youden’s Index, and the kappa coefﬁcient were computed
o assess how well the diagnoses of metastatic nodes based on MRI
nterpretation matched those based on pathologic evaluation at the
hree axillary levels.
Associations between speciﬁc histological characteristics of
reast tumors and the MRI  criteria used to identify lymph node
etastasis were evaluated by binary logistic regression analysis.
hey were put into regression equations to determine which char-
cteristics best predicted lymph node metastasis (Tables 4 and 5).
redicted probability of every criterion was cumulated simultane-
usly in binary logistic regression equation, and graphed as receiver
perating characteristics (ROC) curves. Sensitivity, speciﬁcity, odds
atio (R2), and the area under the ROC curve (AUC) were examined
o help select criteria for diagnosing axillary lymph node metastasis
Tables 4 and 5).
To improve the predictive value over that of breast tumor MRI
riteria, lymph node MRI  criteria were assessed with ROC curves to
dentify the optimal cut-off value. Sensitivity, speciﬁcity, Youden’sIndex, odds ratio (R2), and AUC were used to evaluate these thresh-
olds.
The most informative MRI  criteria (compared of sensitivity,
speciﬁcity, Youden’s Index, odds ratio, and AUC) for predicting
axillary lymph node metastasis were chosen to create a lymph
node MRI  scoring system, every remained criterion was  scored
as zero, one, or two by two radiologists (Table 7), total score of
every node was ranging from zero (meaning a low probability of
metastasis) to 10 (meaning a high probability of metastasis). Cut-
off values were computed from the ROC curve at the point with
the largest Youden’s Index. Sensitivity, speciﬁcity, odds ratio, and
AUC were calculated to evaluate the predictive ability of remained
criterion.
All data met  the assumptions of the tests used to analyze them.
Alpha was set at 0.05, and all tests were two  tailed. All estimates
are accompanied by 95% conﬁdence intervals (95% CI). All statisti-
cal analyses were performed with the SPSS 17.0 software package
(SPSS Inc., Chicago, IL, USA).
3. Results
From tissue samples of 136 women (mean age, 44 years; range,
20–67 years), we counted140 breast lesions (58 benign; 82 malig-
nant), and 1242 axillary lymph nodes (1100 benign and 142
malignant, as established by pathological analysis).
3.1. Pathology results
Of the 1242 axillary lymph nodes assessed, 1184 from 79 breast
cancer patients (34 pN0, 19 pN1, 13 pN2, 2 pN3; AJCC TNM
staging 2010 [3]) including 142 metastatic nodes, were identi-
ﬁed by pathologic analysis, yielding a mean (SD) of 15 nodes per
patient (SD = 6; range: 1–30). The other 58 nodes came from 57
women  with breast neoplasm (one women with bilateral breast
neoplasm, one in each breast), a total of 58 breast neoplasm
and 58 lymph nodes from 57 patient conﬁrmed by pathological
biopsy.
The mean size of the 251 nodes, as measured along the great-
est dimension on dynamic contrast-enhanced images, was  18 mm
(range, 5–58 mm).  Of the 142 malignant nodes, 8 (5.6%) were
smaller than 5 mm and missed in MR images, they were detected
only from pathologic analysis.Of 140 breast lesions, 7 (5%) were ductal carcinoma in situ,
65 (46%) were invasive ductal carcinoma, 8 (6%) were invasive
lobular carcinoma, and 2 (1%) were lymphomas. Of the 58 (43%)
benign lesions, 25 (18%) showed ﬁbrocystic changes (including
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Table  2
Apparent diffusion coefﬁcient value (b = 500) of breast tumor and axillary lymph node.
ADC value (b = 500, ×10−3 mm/s)
N Mean SD Levene’s testa T-Testb
F P value MD  t P value 95% CI
Breast tumor
Benign 58 1.5531 0.1445 8.16 0.005 0.2797 10.26 0.000 0.2258 0.3336
Malign  82 1.2734 0.1772
Lymph node
Benign 117 1.7651 0.3509 65.40 0.000 0.3958 11.04 0.000 0.3250 0.4666
Malign 134 1.3693 0.1766
SD: std. deviation; 95%CI: 95% conﬁdence interval of the difference; MD:  mean difference.
ce dat
st.
c
ﬁ
(
3
3
m
t
m
(
r
aa Levene’s test for equality of variances. These data were heterogeneity of varian
b T-Test for equality of means of different groups with independent-samples-t-te
alciﬁcations), 13 (9%) were intraductal papillomas, 18 (13%) were
broadenomas, 1 (1%) showed acute inﬂammatory change, and 1
1%) showed chronic inﬂammatory changes.
.2. Magnetic resonance imaging results
.2.1. Dynamic contrast-enhanced magnetic resonance imaging
A total of 134 (94%) nodes larger than 5 mm detected on MRI
aps were diagnosed as malignant on MRI, but only 108 (81%) were
rue positives.
The mean (SD) length of short-axis and long-axis between the
etastatic and benign nodes were 10.3 (4.3) mm vs. 9.2 (3.1) mm
P < 0.001); 14.6 (5.5) vs. 5.16 (2.5) mm  (P < 0.001), respectively. The
atio of the shortest dimension to the longest one of the metastatic
nd benign nodes was 0.71 (0.12) vs. 0.55 (0.16) (P < 0.001).
Fig. 5. Receiver operating characteristics curves for the individual criteria of the nea (P < 0.05).
Of the 251 nodes, 85 (34%) had irregular contours, and the pro-
portion of early-stage enhancement of 161 nodes (64%) was more
than 50%. The shape of the TIC was  persistent in 72 (29%) nodes,
plateau in 81 (32%) nodes, and washout in 98 (39%) nodes.
For malignant lymph nodes diagnosed from MR  images, the
positive predictive value, positive likelihood radio, sensitivity,
accuracy, Youden’s Index, and kappa values were highest for nodes
from level I and lowest in those from level III, whereas the nega-
tive predictive value and the negative likelihood radio were highest
in level III and lowest in level I. The results showed that the MRI
diagnosis was  affected by anatomic factors (Table 1).3.2.2. Diffusion-weighted-magnetic resonance imaging
The average (SD) ADC values of malignant breast tumors were
signiﬁcantly lower than those of benign tumors (b = 500, 1.2734
w preoperative magnetic resonance scoring system for axillary lymph nodes.
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Table  3
Apparent diffusion coefﬁcient value (b = 800) of breast tumors and axillary lymph nodes.
ADC value (b = 800, ×10−3 mm/s)
N Mean SD Levene’s testa T-Testb
F P value MD t P value 95% CI
Breast tumor
Benign 58 1.4450 0.1211 23.71 0.000 0.2911 11.01 0.000 0.2388 0.433
Malign 82 1.1539 0.1912
Lymph node
Benign 117 1.5513 0.3134 100.85 0.000 0.3691 11.94 0.000 0.3081 0.4302
Malign 134 1.1822 0.1244
SD: std. deviation; 95%CI: 95% conﬁdence interval of the difference; MD:  mean difference.
a Levene’s test for equality of variances. These data were heterogeneity of variance data (P < 0.05).
b T-Test for equality of means of different groups with independent-samples-t-test.
Table 4
Correlations between metastatic lymph nodes and features of breast tumors with binary logistic regression analysis and ROC curve analysis.
Breast tumor features Lymph node metastasis
Binary logistic regression analysis ROC curve analysisa
Se, % Sp, % OR (R2) 95%CI P value AUC 95% CI P value
Tumor diameter 65.7 84.6 1.01 1.07–1.12 0.000 0.82 0.77–0.87 0.000
Tumor  pathologic type 94.8 54.7 0.58 0.49–0.68 0.000 0.70 0.63–0.77 0.000
Tumor  ADC (b = 500) 86.6 72.6 0.00 0.00–0.007 0.000 0.82 0.77–0.88 0.000
Tumor  ADC (b = 800) 88.1 72.6 0.00 0.000–0.001 0.000 0.85 0.80–0.90 0.000
Tumor  TIC 79.1 69.2 6.49 4.04–10.43 0.000 0.79 0.73–0.84 0.000
ER  63.4 41.9 0.87 0.72–1.04 0.126b 0.55 0.48–0.62 0.151b
PR 100 3.4 0.94 0.77–1.15 0.557b 0.52 0.45–0.59 0.601b
CerbB2 100 0 1.05 0.86–1.29 0.620b 0.51 0.44–0.58 0.770b
VEGF 85.8 29.9 1.20 0.97–1.48 0.103b 0.56 0.49–0.63 0.094b
KI67 65.7 43.6 1.01 1.00–1.02 0.056b 0.57 0.50–0.64 0.055b
S  unde
ode o
[
[
l
(
[
n
3
c
P
(
T
C
Se: sensitivity; Sp: speciﬁcity; OR: odds ratio; 95% CI: asymptotic 95% CI; AUC: area
a ROC curve analysis of predicted ability for present at least 1 metastatic lymph n
b All coefﬁcients were not statistically signiﬁcant at the 0.05 level.
0.1772] vs. 1.5531 [0.1445]; b = 800, 1.4550 [0.1211] vs.1.1539
0.1912]), whereas similar characteristics were found in metastatic
ymph nodes and they were lower than those of benign nodes
b = 500, 1.3693 [0.1766] vs. 1.7651 [0.3509]; b = 800, 1.1822
0.1244] vs. 1.5513 [0.3134]). However, most of the ADC values of
odes were larger than those of breast tumors (Tables 2 and 3).
.3. Agreement between diagnostic methodsThe diagnoses of lymph nodes by MRI  were signiﬁcantly
orrelated with those of the pathologic examination (r = 0.76;
 = 0.000). Breast tumor diameter, pathologic types, ADC value
b = 500 and b = 800), and TIC types were associated with lymph
able 5
orrelations between metastatic lymph nodes and features of nodes with binary logistic 
Lymph nodes features Lymph node metastasis
Binary logistic regression analysis 
Se, % Sp, % OR (R2) 
Short axis length 83.6 81.2 1.79 
Long  axis length 78.4 70.9 1.47 
Shape  (short-long axis ratio) 79.1 68.4 1337.26 
Margin 51.5 86.3 6.70 
Anatomical location 26.1 97.4 11.88 
DCE-MRI, early stage enhancement rate 97.0 73.5 34.70 
DCE-MRI, time intensity curve (TIC) 53.7 77.8 5.30 
High  signal on DWI  mapb 85.8 84.6 33.29 
ADC  value (b = 500) (×10−3 mm/s) 78.4 65.8 0.003 
ADC  value (b = 800) (×10−3 mm/s) 82.1 70.1 0.000 
e: sensitivity; Sp: speciﬁcity; OR: odds ratio; 95% CI: asymptotic 95% CI; AUC: area unde
a ROC curve analysis of predicted ability for present at least 1 metastatic lymph node o
b High signal showed of node on DWI  map  were identiﬁed.
c All coefﬁcients were statistically signiﬁcant at the 0.001 level.r the ROC curve.
f regression equation.
nodes metastasis (Table 4). However, the correlations between
immunohistochemistry values—estrogen receptors (ER), proges-
terone receptor (PR), c-erbB-2, vascular endothelial growth factor
(VEGF), Ki67—were not statistically signiﬁcant (P > 0.05, Table 4).
Features of lymph nodes visible on MRI  were also signiﬁcantly
correlated with metastatic nodes: ADC values, TIC type, early
enhancement rate, long axis, short axis, shape, margin, and location
(P < 0.001; Table 5). Round or ovoid (a ratio between the transverse
and longitudinal diameters of more than 0.6) shapes were also MRI
morphological characteristics of metastatic nodes, and a short axis
longer 5.5 mm was  the predicted threshold value for malignancy
(Table 6). Cut-off ADC values for predicting metastatic nodes were
1.3508 × 10−3 mm/s (b = 500; sensitivity, 97.0%; speciﬁcity, 54.5%;
regression analysis and ROC curve analysis.
ROC curve analysisa
95%CI P valuec AUC 95% CI P valuec
1.56–2.05 0.000 0.89 0.85–0.93 0.000
1.32–1.64 0.000 0.84 0.79–0.88 0.000
180.14–9927.28 0.000 0.78 0.72–0.84 0.000
3.58–12.54 0.000 0.69 0.62–0.76 0.000
3.60–39.26 0.000 0.62 0.55–0.69 0.000
14.97–80.47 0.000 0.87 0.83–0.92 0.000
3.51–8.02 0.000 0.80 0.74–0.86 0.000
16.56–66.93 0.000 0.85 0.80–0.90 0.000
0.001–0.013 0.000 0.84 0.79–0.88 0.000
0.000–0.002 0.000 0.87 0.82–0.91 0.000
r the ROC curve.
f regression equation.
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Table  6
Diagnostic performance characteristics of individual MRI  criteria for diagnosing metastatic axillary lymph nodes, by optimal cut-off values.
Node MRI  criteria Cut-off value ROC curve Se, % Sp, %
Valuea YI OR 95% CI AUCb 95% CI
Short axis length 5.5 (mm)  0.66 36.89 16.76–81.22 0.89 0.85–0.93 93.3 72.6
Long  axis length 9.5 (mm)  0.52 13.17 6.91–25.09 0.84 0.79–0.88 88.1 64.1
Shape  (short-long axis ratio) 0.62 0.48 8.12 4.61–14.32 0.78 0.72–0.84 77.6 70.1
Margin 0.5 (mm) 0.38 6.70 3.58–12.54 0.69 0.62–0.76 51.5 86.3
Anatomical location 1.5 0.23 9.61 3.29–28.01 0.62 0.55–0.69 25.4 96.6
DCE-MRI, early stage enhancement rate 50% 0.71 90.16 30.73–264.53 0.87 0.83–0.92 97.0 73.5
DCE-MRI, time intensity curve (TIC) 0.5 0.60 205.28 27.73–1519.86 0.80 0.74–0.86 99.3 60.7
High  signal in DWI  map 0.5 0.70 33.29 13.60–113.21 0.85 0.80–0.90 85.8 84.6
ADC  value (b = 500) (×10−3 mm/s) 1.6795 0.52 39.25 13.60–113.21 0.84 0.79–0.88 97.0 54.7
ADC  value (b = 800) (×10−3 mm/s) 1.3508 0.61 34.93 14.91–81.83 0.87 0.82–0.91 94.8 65.8
New-scoring system 4.5 0.83 119.49 48.84–292.36 0.95 0.92–0.98 92.5 90.6
Y ROC c
a
A
(
0
t
s
c
t
t
s
t
i
A
S
T
P
a
s
b
t
a
s
a
bI: Youden’s Index; OR: odds ratio, 95% CI: asymptotic 95% CI, AUC: area under the 
,b All coefﬁcients are statistically signiﬁcant at the 0.001 level.
UC, 0.84; 95%CI, 0.79–0.88; P < 0.001) and 1.6795 × 10−3 mm/s
b = 800, sensitivity, 95.8%, speciﬁcity, 65.8%; AUC, 0.87; 95%CI,
.82–0.91; P < 0.001; Table 6).
The criteria for diagnosing breast tumors were no better than
hose for diagnosing lymph nodes; AUC, odds ratio, sensitivity, and
peciﬁcity were similar (Tables 4 and 5). Considering the problems
reated by an MRI  misdiagnose of breast tumor (false positive) and
he existence of occult breast cancer, we based our diagnostic cri-
eria solely on MR  images of nodes. The ADC values were collinear,
o only b = 800 was entered in new regression equation.
Cut-off values for these retained MRI  criteria (Table 6) were used
o create an MRI  axillary lymph node scoring system standard-
zed according to the terms and classiﬁcations of the Atlas of the
merican College of Radiology’s Breast Imaging Reporting and Data
ystem (Table 7). A threshold score of 4.5 (Table 6) had a speciﬁcity
able 7
oint scores of a new MRI  scoring system for the preoperative diagnosis of metastatic
xillary lymph nodes in women with breast cancer. Scores of 6 or more are 96% sen-
itive and 83% speciﬁc for the diagnosis of metastatic nodes. Cut-off values between
enign and malignant lymph nodes were deﬁned using receiver operating charac-
eristic curves.
Criteria Descriptions Scores
Shape Long ellipsoid; ratioa ≥ 0.6 0
Round; ratioa < 0.6 1
Margin Smooth, isolated 0
Irregular, symphysic 1
Anatomical locationb Level III 0
Level II 1
Level I 2
DCE-MRI, early stage
enhancement ratec
<50% 0
50–100% 1
>100% 2
DCE-MRI, time intensity
curve (TIC)
Type I, persistent 0
Type II, plateau 1
Type III, washout 2
High  signal in DWI  map No 0
Yes 1
ADC  value (b = 800)d ≥1.3508 × 10−3 mm/s 0
(ROI ≥ 5 mm2) <1.3508 × 10−3 mm/s  1
Maximum score 10
a Ratio = short diameter/long diameter.
b Anatomical location: level I – the area of laterals pectoralis minor; level II – the
rea under pectoralis minor; level III – the area at the top of pectoralis minor.
c Early stage enhancement rate Si = (Smax 1–3 min − Spre)/Spre × 100%. Spre: the base
ignal value before enhancement; Smax 1–3 min: the maximum signal value in 1–3 min
fter enhancement.
d ADC value chose b = 800 because the predicted value was  better than that of
 = 500 analyzed in our research.urve, Se: sensitivity; Sp: speciﬁcity.
of 90.6%, a sensitivity of 92.5%, and an area under ROC curve of 0.95
(asymptotic 95% CI, 0.92–0.98; P < 0.001). The AUC of the proposed
scoring system was larger than that of any single criterion and had
the best predictive ability (Fig. 5).
4. Discussion
Pathologic axillary lymph node staging [3] is one of the most
important predictors of breast cancer recurrence. However, diag-
nose of these nodes currently requires pathologic analysis of tissue
biopsy or dissection after surgery, both of which are invasive
procedures. Standard double breast coils simultaneously, and non-
invasively, evaluate both breasts and axillary lymph nodes during
MRI  breast cancer staging [10], and other new technologies, such
as DCE-MRI and DWI-MRI, are now widely used to diagnose breast
cancer. However, verifying in vivo diagnoses based on MR  images
of speciﬁc nodes with pathologic analysis of tissue from the same
node remains difﬁcult. Furthermore, the use of DCE-MRI and DWI-
MRI  with the contrast agent GD-DTPA for diagnosing metastatic
axillary lymph nodes has not been widely studied, and the results
have been conﬂicting. We  addressed both problems.
We  identiﬁed several morphological characteristics of axillary
lymph nodes that have diagnostic value: tumor diameter, the
lengths of the short and long axes, shape (the short:long axis ratio),
irregular margins, necrosis, capsular effraction or the absence of
lymph node hila, and anatomic location. We  also identiﬁed several
functional MRI  characteristics of these nodes with diagnostic value:
ADC values (b = 500 and 800), the shape of the TICs, the early stage
enhancement rate, and high signals on the DWI  map. The sensi-
tivity of these characteristics ranged from 51.5% to 94.8%, and the
speciﬁcity ranged from 54.7% to 97.4% (Tables 4 and 5).
Our results are similar to those of others. In a meta-analysis,
Choi et al. [11] reported the diagnostic performance of CT, MRI,
and positron emission tomography or computed tomography for
detecting metastatic lymph nodes in patients with cervical can-
cer. In region- or node-based data analysis, the sensitivity of MRI
with the contrast agent GD-DTPA was  38%, and the speciﬁcity was
97%. Harada et al. [12] assessed the diagnostic performance char-
acteristics of morphologic variables visible on MRI  with ultrasmall
superparamagnetic iron oxide, a contrast agent not approved by the
FDA for diagnostic use. The sensitivity of these morphologic vari-
ables was 36.5%, speciﬁcity was  94.1%, and overall accuracy was
81.0%.
To acquire a DCE-MR image, an intravenous bolus injection of a
low-molecular-weight contrast agent is followed by fast-sequence
image acquisition to measure the signal enhancement over time as
the contrast agent travels through the tumor vasculature. The signal
enhancement TIC may  differentiate malignant from benign breast
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Fig. 6. Different position of ROI affected the TIC type, 3 axillary lymph nodes of a 45-year-old breast cancer patient. (A) The largest one (Nos. 1 and 2) was a pathological
conﬁrmed metastatic node; the other little two (Nos. 3 and 4) were benign ones. (B) Maximum slope of increase pseudo-color map  (MSI map) automatic generated by SUN
ADW  1.2 workstation (General Electric, Milwaukee, WI,  USA). (C) Signal enhancement ratio pseudo-color map  (SER map) generated by SUN ADW 1.2 workstation. (D) Sagittal
dynamic contrast enhanced scanning with fat-suppressed T1-weighted sequences (3D-gradient echo imaging). (E) Time-intensity curves (TICs) of 4 ROI, average area of ROI
was  20 mm2 (100 PIX). (F) High signal the largest node (No. 1) was  in DWI  map  (b = 800) (White arrow). (B–F) No. 1 ROI on hot point (red area of maximum slope of increase
map)  showed typical washout type TIC-type III (D), it revealed that malignant one; but No. 2 ROI of the same metastatic node showed plateau type-type II, similar to No. 3
and  No. 4, it would be difﬁcult to make the diagnose of metastatic one because there were part of benign lesions also identiﬁed on this TIC type, so, how to chose a suitable
R (No. 1
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mOI  affected accuracy of MRI  diagnose. (G) Pathological result of metastatic node 
hite  arrows showed the cancer evidences in the node) (Hematoxylin & Eosin, 20
Hematoxylin & Eosin, 100×).
eoplasm. Time-intensity curves have been classiﬁed as persistent,
lateau, or washout curves [8]. Persistent curves have been associ-
ted with benign disease, and washout curves have been associated
ith cancer [13]. In our study, the signal was often disturbed by
espiration and the pulses of the axillary blood vessels, producing
agged curves that were difﬁcult to classify. To solve this problem,
e tried having patients hold their breaths during the scan, short-
ning the scanning time, changed scan sequences, tried different
hicknesses, and so on a pilot trial with 6 breast cancers, at last,
uitable imaging protocols were remained in this study for further
esearch.
Washout TICs and an early enhancement rate greater than 50%,
specially when it peaked within 3 min, were strong predictors
f lymph node metastasis. In addition, choosing a suitable ROI
ocation conﬁrmed that was the most important effect factors in
ost process: On DEC-MRI map, ROI should locate on the largest
nhanced ratio position suggested on maximum slope of increase
seudo-color map  and signal-enhancement ratio pseudo-color
ap  created by workshop in the same time (Fig. 6); On DWI-MRI
ap, ROI should be placed at the hottest point of the EADC pseudo) (Hematoxylin & Eosin, 100×). (H)  Pathological result of metastatic node (No. 1,
) Pathological result of the other two benign nodes tied together with fatty tissue
illustration with the lowest ADC value and that it should not
extend beyond the range of the DWI  high-signal area (Fig. 7).
Choosing a suitable ROI with these criteria was greatly improved
accuracy. Thus, although choosing an ROI affected the diag-
nostic results, few authors have addressed this problem. We
believe that this ﬁnding has important technical and clinical
implications [14].
Diffusion-weighted MRI  reﬂects the Brownian motion of water
molecules, which provides information about the cellular environ-
ment [15]. The lower ADC values of malignant tumors are the result
of more condensed cells and, consequently, the restricted diffu-
sion of water molecules, which differs from that in benign or cystic
tumors. In our study, DWI-MRI of the breast was highly sensitive
for detecting breast tumors and malignant axillary lymph nodes.
Small ADC values have been conﬁrmed in the literature as another
characteristic of malignant breast tumors [16]. However, few stud-
ies have reported the cut-off value for distinguishing metastatic
from benign axillary lymph nodes. We  identiﬁed these threshold
ADC values as b = 500 and 800 early in our study, and we  found that
values for metastatic axillary lymph nodes were larger than those
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Fig. 7. Different positions of the region of interest affected the apparent diffusion coefﬁcient (ADC) value in a 48-year-old woman with breast mucinous adenocarcinoma.
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DA)  There were no obvious differences in the original graph of the three regions of
,  which is greater than signal No. 3 on the exponential apparent diffusion coefﬁcie
hich  is less than the value of No. 3 on the ADC pseudo illustration (rings). (D) Mic
or malignant breast tumors. The same biological origins and conse-
uently the similar biologic actions of metastatic lymph nodes and
orresponding malignant breast tumors might explain their similar
unctional MR  imaging characteristics.
Irregular contours, necrosis, and missing hila or capsular
ffraction were not common in our study. The frequency of
hese characteristics differs among studies, perhaps because most
atients had early disease in which the morphological changes of
ymph nodes were not yet obvious. Luciani et al. [5] identiﬁed the
haracteristics of metastatic nodes ex vivo and determined that a
-mm-long short axis, as measured on 1.5T-MR images, provided
he best predictive value for diagnosing malignant nodes (sen-
itivity, 78.6%; speciﬁcity, 62.3%). Irregular contours (sensitivity,
5.7%; speciﬁcity, 96.7%), central nodal hyper-intensity on infrared
maging T2 WI  (sensitivity, 57.1%; speciﬁcity, 91.4%), and a cor-
ical thickness greater than 3 mm  (speciﬁcity, 63.6%; speciﬁcity,
3.2%) were also signiﬁcantly associated with metastatic nodes.
hese results are similar to those provided by ultrasonography of
etastatic axillary lymph nodes [17,18].
Inﬂamed enlarged nodes had the greatest false-positive diag-
oses. One possible explanation for this ﬁnding is that the contrast
gent easily penetrated the inﬂammation-damaged capillary walls,
aking them visible on immediate enhancement. Another possible
xplanation is that inﬂammation may  have damaged and swollen
he cells, increasing tissue tension, restricting Brownian motion,
nd decreasing ADC values.
Identifying metastatic lymph nodes solely on morphological cri-
eria remains challenging. However, MR  images can reveal not only
orphological but also functional characteristics of the tumors,ncluding metabolism, perfusion, and diffusion. The new scoring
ystem also incorporates these functional characteristics, which are
eﬁned using the standards in the Breast Imaging Reporting and
ata System.st (rings) on diffusion weighted images. (B) Signal No. 1 is greater than signal No.
eudo illustration (rings). (C) ADC value of No. 1 is less than the ADC value of No. 2,
ic appearance of the breast tumor (Hematoxylin & Eosin, 100×).
Diagnostic accuracy was highest for nodes from level I and low-
est in those from level III (P < 0.001), perhaps because the multiple
and complex tissues around the nodes in level III did not have
enough fat tissue to provide the contrast needed by the radiologists
to identify target nodes.
4.1. Limitations of the study
One limitation of the study was  that, as described earlier, MR
images were not suitable to identify lymph nodes smaller than
about 5 mm.  This limitation prevented the detection of 8 of 142
(5.6%) malignant nodes. Higher-resolution MRI  [19], may  solve this
problem. Also, few of the women in our study had advanced breast
cancer [mean (SD) breast tumor diameter, 33 mm (14 mm); range,
10–60 mm],  so the number of metastatic nodes was small; only 142
of the 1184 nodes obtained during surgery were detected by MRI.
And, the pathologic analysis in our study was more intense than
that likely to be found in clinical practice. More advanced breast
cancer with more axillary lymph nodes metastasis enrolled would
be useful to test this explanation.
Another puzzle was the negative results of the logistic
regression analysis about the relationship between these immuno-
histochemistry results (estrogen receptors, progesterone receptor,
c-erbB-2, vascular endothelial growth factor, and Ki6) and lymph
nodes metastasis. Although, Dafni et al. [20] found that increased
expression of vascular endothelial growth factor was associated
with increased lymph node metastases. More data are needed to
answer this question.5. Conclusions
Metastatic axillary lymph nodes can be diagnosed by contrast-
enhanced MR in women  with early breast cancer. Metastatic nodes
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ere more likely to be ovoid or round (when the ratio of the lengths
f the long and short axes was 0.6 mm  or greater) and to have irreg-
lar margins; early enhanced in 3 min, low ADC values (b = 800:
DC ≤ 1.3508 × 10−3 mm/s; b = 500: ADC ≤ 1.6795 × 10−3 mm/s);
nd type III (washout) time-intensity curves. When these charac-
eristics are scored in our proposed 10-point system, a score of
.5 or above was 92.5% sensitive and 90.6% speciﬁc for identify-
ng metastatic nodes preoperatively (area under ROC curve, 0.95).
his new lymph node scoring system uses a more standardized
escription of lymph nodes and has better diagnostic accuracy.
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